Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
CTMedic's Profile
Displaying 1401-1450 of 1653 result(s).
CYDY CytoDyn Inc
08/04/2020 11:00:37 PM
I am in no way a fan of HCQ or Remd (6)
CYDY CytoDyn Inc
08/04/2020 10:50:00 PM
I don't know that ignoring MDV is t (4)
CYDY CytoDyn Inc
08/04/2020 10:43:18 PM
Thanks for the reminder of the Mara (1)
CYDY CytoDyn Inc
08/04/2020 7:53:33 PM
A decent general article on the imm
CYDY CytoDyn Inc
08/04/2020 7:09:28 PM
I believe Dr. Lalezari mentioned me (1)
CYDY CytoDyn Inc
08/04/2020 6:46:38 PM
The challenge is that nearly everyo (2)
CYDY CytoDyn Inc
08/04/2020 6:29:18 PM
MDV, Thanks for the reply. I have r (1)
CYDY CytoDyn Inc
08/04/2020 6:23:28 PM
In a trial, whatever delivery metho
CYDY CytoDyn Inc
08/04/2020 4:39:00 PM
Are we going to skip results from C (1)
CYDY CytoDyn Inc
08/04/2020 4:20:00 PM
I thought there had been some evalu
CYDY CytoDyn Inc
08/04/2020 2:59:06 PM
Thank you.
CYDY CytoDyn Inc
08/04/2020 2:28:13 PM
I’ve never been part of a fan clu
CYDY CytoDyn Inc
08/04/2020 1:53:03 PM
Anti-spike antibody similar to Rege (1)
CYDY CytoDyn Inc
08/04/2020 1:47:35 PM
This is why the trials are randomiz (1)
CYDY CytoDyn Inc
08/04/2020 1:06:07 PM
The availability of remdesevir is l (1)
CYDY CytoDyn Inc
08/04/2020 12:23:02 PM
Salmon fishing is on my bucket list
CYDY CytoDyn Inc
08/04/2020 12:20:56 PM
I would guess the rapid improvement
CYDY CytoDyn Inc
08/04/2020 12:17:56 PM
I sold exact sciences “way back†(4)
CYDY CytoDyn Inc
08/03/2020 10:26:12 PM
The short attacks suck, I agree. My (3)
CYDY CytoDyn Inc
08/03/2020 10:10:40 PM
My guess (certainly may be wrong),
CYDY CytoDyn Inc
08/03/2020 10:09:23 PM
No one should be concerned about sh (2)
CYDY CytoDyn Inc
08/03/2020 9:47:47 PM
Thank you Babaji. I did not know th
CYDY CytoDyn Inc
08/03/2020 9:45:22 PM
CDiddy, That appears to be exactly (2)
CYDY CytoDyn Inc
08/03/2020 9:30:59 PM
He acquired 323k shares as a grant (1)
CYDY CytoDyn Inc
08/02/2020 1:32:55 PM
Dr. Pourhassan stated in Thursday's (3)
CYDY CytoDyn Inc
08/01/2020 7:08:11 PM
It may be that Cytodyn is not able
CYDY CytoDyn Inc
08/01/2020 6:37:48 PM
Wayne Brady now on the reboot. I fi
CYDY CytoDyn Inc
08/01/2020 4:46:24 PM
I did not see it explicitly indicat
CYDY CytoDyn Inc
08/01/2020 4:42:40 PM
My understanding of DSMC and Dr. Po (1)
CYDY CytoDyn Inc
08/01/2020 4:01:24 PM
Craigakess, I apologize for letting (2)
CYDY CytoDyn Inc
08/01/2020 2:16:50 PM
I am excited, thanks. Collectively (3)
CYDY CytoDyn Inc
08/01/2020 1:57:07 PM
I DISAGREE 100% (yelling intended). (7)
CYDY CytoDyn Inc
08/01/2020 12:07:48 PM
BigtimerDC It seems to me premature (6)
CYDY CytoDyn Inc
07/31/2020 6:25:58 PM
Does anyone know of non-Hodgkin lym
CYDY CytoDyn Inc
07/31/2020 3:19:05 PM
I find it very difficult to believe (4)
CYDY CytoDyn Inc
07/31/2020 2:38:56 PM
With Covid raging in Texas and two
CYDY CytoDyn Inc
07/31/2020 8:35:37 AM
It is getting to the point that har (2)
CYDY CytoDyn Inc
07/31/2020 6:39:52 AM
The correlation for Stuttgart price (1)
CYDY CytoDyn Inc
07/31/2020 6:22:55 AM
Jlang, You are correct. However som (1)
CYDY CytoDyn Inc
07/31/2020 6:18:12 AM
A physician colleague of mine discu (2)
CYDY CytoDyn Inc
07/30/2020 8:22:31 PM
Cocoob, I believe you are correct. (1)
CYDY CytoDyn Inc
07/30/2020 7:01:23 PM
I believe Regeneron included SAEs a (1)
CYDY CytoDyn Inc
07/30/2020 6:52:56 PM
46153. Excellent summary by z_smith
CYDY CytoDyn Inc
07/30/2020 6:51:18 PM
If M/m results very positive, I exp (2)
CYDY CytoDyn Inc
07/30/2020 6:24:28 PM
I’ll have to listen to the CC aga
CYDY CytoDyn Inc
07/30/2020 5:51:13 PM
Question was asked and answered abo (1)
CYDY CytoDyn Inc
07/30/2020 5:48:19 PM
I sent an email as well, suggesting (9)
CYDY CytoDyn Inc
07/30/2020 4:54:36 PM
Dr. Pourhassan stated a PR will be
CYDY CytoDyn Inc
07/30/2020 4:53:26 PM
knuckleheads repeating asked and an
CYDY CytoDyn Inc
07/30/2020 4:34:11 PM
Did anyone catch what number one di
Go to page:
  • << First
  • < Previous
  • 28
  • 29
  • Next >

Recent Articles

  • Kering's Monthly Share and Voting Rights Breakdown for 2025
  • Exploring Altus Group's Latest Insights on European CRE Trends
  • Disney Shifts Marvel Productions from Georgia to UK for Savings
  • Riders Prefer Waymo Robotaxis Over Uber Drivers in Atlanta
  • GigaCloud Technology Launches $111 Million Share Repurchase Initiative
  • GigaCloud Technology Welcomes Kerry Lebensburger to Board
  • Manipal Hospitals Expands Cancer Care with Dr. Dabas' Expertise
  • Enhanced Shareholder Benefits from 180 Degree and Mount Logan Merger
  • E-bike Market Expected to Reach $87.2 Billion Through Innovation
  • Breakthrough Therapy Designation for Izalontamab Brengitecan
  • Heineken N.V. Shares Progress on Major Buyback Initiatives
  • Celebrating a Decade of Innovation: IDEAYA Biosciences R&D Day
  • Heineken Holding N.V. Shares Buyback Program Update and Details
  • KuCoin Pay and Umy Revolutionizing Travel Payments with Crypto
  • KuCoin Pay Teams Up with Umy to Enhance Travel with Crypto
  • Yuchai Delivers Natural Gas Buses, Enhancing Public Transport
  • Echosens and Novo Nordisk Collaborate to Enhance MASH Awareness
  • Air Canada Navigates Challenges with Suspended Guidance for 2025
  • Revolutionizing Wealth Management with Agentic AI Technology
  • Three Sticks Wines Achieves Excellence in Recent Awards
  • Metal Supermarkets Awards Scholarships to Future Trades Experts
  • CaringKind Welcomes Dr. Kendra Ray as Chief Research Officer
  • Innovative Merger Transforms Indoor Farming Landscape
  • Supporting Michigan Families: Consumers Energy's Latest Initiative
  • Rubenstein Law's Megan Schmidt Joins Esteemed Leadership Program
  • Transforming Climate Control: The Rise of Smart HVAC Solutions
  • Understanding Consumer Credit Trends Amid Economic Challenges
  • Airsed Securities Launches Innovative Trading Platform for Investors
  • Exciting Trading Opportunities with XXKK Exchange's Bonus Offer
  • Kering Reports August 2025 Shareholder Voting Details
  • Opportunities for Sarepta Therapeutics Investors Amid Lawsuit
  • Understanding Caisse Française de Financement Local's Asset Quality Insights
  • Stock Futures Slip as Market Anticipates Earnings Reports
  • Strengthening Cancer Care: Dr. Dabas Joins Manipal Hospitals
  • Understanding the Impacts of a Steepening Yield Curve
  • Emini Futures Reach New Heights in September Trading Surge
  • Earnings Season Insights: Key Trends and Market Movements
  • Natural Language Understanding Market Growth and Trends Ahead
  • Sisecam Reports Strong Financial Performance with 101 Billion TL Sales
  • Understanding Disclosure Trends with AXA Investment Managers
  • New Class Action Lawsuit Presented by Schall Law Firm for RxSight
  • RxSight, Inc. Under Investigation: What You Need to Know
  • Sisecam Achieves Remarkable Sales Growth with 101 Billion TL
  • Fibank Secures €50 Million Bond Placement to Boost Stability
  • Fibank's Innovative €50 Million Bond Issue Boosts Growth Plans
  • Caisse Française de Financement Local Publishes Quality Report
  • Solo Bitcoin Miner Celebrates Windfall of Over $360,000
  • Boliden Addresses Changes in Finnish Mining Tax Proposals
  • Market Dynamics: Easing Strategies and the Role of Technology
  • Kandi Technologies Partners with CATL for Battery Swap Stations
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site